Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 250 results in range #751 to #1,000.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. NUT-2Efficacy Assessment Of Meloxicam, A Preferential Cyclooxygenase-2 Inhibitor, In Acute Coronary Syndromes Without St-Segment Elevation. The Nonsteroidal Anti-Inflammatory Drugs In Unstable Angina Treatment-2 (Nut-2) Pilot Study
  2. F.I.R.E.Efficacy Of Fx06 In The Prevention Of Myocardial Reperfusion Injury Trial
  3. TIMICEfficacy Of Immunosuppressive Therapy In Patients With Virus-Negative Inflammatory Cardiomyopathy
  4. RISEfficacy Of Multiple Risk Factor Intervention In Treated Hypertensive Men
  5. ERICAEfficacy Of Ranolazine In Chronic Angina
  6. EVERESTEfficacy Of Vasopressin Antagonism In Heart Failure: Outcome Study With Tolvaptan
  7. Eisenmenger’s SyndromeEisenmenger’s Complex
  8. EFICATEjection Fraction In Cardiac Transplant Patients
  9. EPOSElective Pci In Outpatient Study
  10. Electrical chargeElectric charge
  11. ChargedElectric charge
  12. ElectricalElectric charge
  13. PositiveElectric charge
  14. Positive chargeElectric charge
  15. AVID Electrical Storm SubstudyElectrical Storm Presages Nonsudden Death. The Antiarrhythmics Vs. Implantable Defibrillators (Avid) Trial
  16. User:Amber24paigeElectronic cigarette 24
  17. ESVEMElectrophysiologic Study Versus Electrocardiographic Monitoring Trial
  18. Eli LillyEli Lilly and Company
  19. Elias CoreyElias James Corey
  20. E.J. CoreyElias James Corey
  21. Elixir SulfanilamideElixir Sulfanilamide disaster
  22. ED-IMPACTEmergency Department Impedance Cardiography-Aided Assessment Changes Therapy Sponsor: Cardiodynamics International
  23. EMTALAEmergency Medical Treatment and Active Labor Act
  24. Emil von BehringEmil Adolf von Behring
  25. EASTEmory Angioplasty Vs Surgery Trial
  26. Empty caloriesEmpty calorie
  27. DIG EnalaprilEnalapril Versus Digoxin In Patients With Congestive Heart Failure: A Multicenter Study (Canadian Enalapril Versus Digoxin Study Group)
  28. TulvingEndel Tulving
  29. Duke criteriaEndocarditis diagnosis#Duke Clinical Criteria for the Diagnosis of Infective Endocarditis
  30. Modified Duke CriteriaEndocarditis diagnosis#Duke Clinical Criteria for the Diagnosis of Infective Endocarditis
  31. Modified duke criteriaEndocarditis diagnosis#Duke Clinical Criteria for the Diagnosis of Infective Endocarditis
  32. Modified Duke criteriaEndocarditis diagnosis#Duke Clinical Criteria for the Diagnosis of Infective Endocarditis
  33. ECRISEndocoronary-Rhenium-Irradiation-Study
  34. MATHEndocrine And Renal Effects Of Nifedipine Gastrointestinal Theraputic System In Patients With Essential Hypertension: Results Of A Multicenter Trial
  35. Benign endometrial hyperplasiaEndometrial hyperpasia
  36. EARTHEndothelin Receptor Antagonist Trial In Heart Failure
  37. EVEREST IEndovascular Valve Edge-To-Edge Repair Study
  38. CAVATASEndovascular Versus Surgical Treatment In Patients With Carotid Stenosis In The Carotid And Vertebral Artery Transluminal Angioplasty Study (Cavatas)
  39. EF5Enhanced Fujita Scale
  40. ESPRITEnhanced Suppression Of The Platelet IIb/IIia Receptor With Integrilin TherapyEuropean Study Of The Prevention Of Reocclusion After Initial ThrombolysisEvaluation Of Subcutaneous Proleukin In A Randomized International Trial
  41. ENRICHDEnhancing Recovery In Coronary Heart Disease
  42. ExTRACTEnoxaparin And Thrombolysis Reperfusion For Acute Myocardial Infarction Treatment
  43. ENTIREEnoxaparin And Tnk-Tpa With Or Without Gp IIb/IIia Inhibitor As Reperfusion Strategy In St Elevation Mi (TIMI-23)
  44. EVETEnoxaparin Versus Tinzaparin In Non-St-Segment Elevation Acute Coronary Syndromes
  45. ENCOREnrasentan Cooperative Randomized Evaluation
  46. ECLIPSEEnsure's Vascular Closure Device Speeds Hemostasis Trial
  47. EnvironmentalistEnvironmentalism
  48. Epigastric arteriesEpigastric artery
  49. EponymsEponym
  50. EVA-AMIEptifibatide Versus Abciximab In Primary Pci For Acute St Elevation Myocardial Infarction
  51. Equine infectious anemia virusEquine infectious anemia
  52. Equipment Used in Percutaneous Coronary InterventionEquipment used in percutaneous coronary intervention
  53. HorsetailsEquisetum
  54. ErgometrineErgonovine
  55. Ergotrate MaleateErgonovine
  56. Methylergonovine maleateErgonovine
  57. Eric R. KandelEric Kandel
  58. Erich HuckelErich Hückel
  59. EAGAREstrogen And Graft Atherosclerosis Research Trial
  60. EASTEREstrogen And Stents To Eliminate Restenosis
  61. EPATEstrogen In The Prevention Of Atherosclerosis Trial
  62. EMERASEstudio Multicentrico Estreptoquinasa Republicas De America Del Sur
  63. EPAMSAEstudio Piloto Argentino De Muerte Subita Y Amioda Rone (Argentine Pilot Study Of Sudden Death And Amiodarone)
  64. ERACIEstudio Randomizado Argentino De Angioplastia Vs. Cirugía (Argentine Randomized Trial Of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery In Multivessel Disease)
  65. ECLA GIKEstudios Cardiologicos Latinoamerica Glucose-Insulin-Potassium Pilot Trial
  66. EthicalEthics
  67. ERGOEtomoxir For The Recovery Of Glucose Oxidation
  68. EugenicEugenics
  69. Euro-SPAHEuropean-Sonotherapy Prevention Of Arterial Hyperplasia
  70. EARSEuropean Atherosclerosis Research Study
  71. EAFTEuropean Atrial Fibrillation Trial
  72. ECSTEuropean Carotid Surgery Trial
  73. EUROSTAREuropean Cobalt Stent With Antiproliferative For Restenosis Trial
  74. ECASS IIIEuropean Cooperative Acute Stroke Study III
  75. ECSG-1European Cooperative Study Group For Recombinant Tissue-Type Plasminogen Activator
  76. ECSG-6European Cooperative Study Group For Recombinant Tissue-Type Plasminogen Activator II
  77. ECSSEuropean Coronary Surgery Study Group
  78. ELUTESEuropean Evaluation Of Paclitaxel Eluting Stent
  79. EMITEuropean Mivazerol Trial
  80. EMIATEuropean Myocardial Infarction Amiodarone Trial
  81. EMIP-FREuropean Myocardial Infarction Project—Free Radicals
  82. E-SIRIUSEuropean Sirolimus-Eluting Stent In Coronary Lesions
  83. ESHREEuropean Society of Human Reproduction and Embryology
  84. EURO-SPAHEuropean Sonotherapy Trial To Prevent Arterial Hyperplasia
  85. ESPS2European Stroke Prevention Study 2
  86. ESPS-2European Stroke Prevention Study 2
  87. ESTATEuropean Stroke Treatment With Ancrod Trial
  88. EUTOPIAEuropean Trial On Olmesartan And Pravastatin In Inflammation And Atherosclerosis
  89. EUROPAEuropean Trial On Reduction Of Cardiac Events With Perindopril In Stable Coronary Artery Disease
  90. ELECTEvaluating Enoxaparin (Lovenox) Clotting Times
  91. EPICEvaluation Of C7E3 For The Prevention Of Ischemic Complications
  92. EDGEEvaluation Of Daptomycin (Cidecin) In Gram-Positive Entities
  93. EDGECAPEvaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Community-Acquired Pneumonia
  94. EDGESSTEvaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Complicated Skin And Soft Tissue Infections
  95. EDGEUTIEvaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Complicated Urinary Tract Infection
  96. A to Z, Phase ZEvaluation Of Early Versus Delayed Initiation Of Simvastatin In Patients Who Receive Guideline Based Treatment For Acute Coronary Syndrome
  97. ELITEEvaluation Of Losartan In The Elderly
  98. ENCORE IEvaluation Of Nifedipine And Cerivastatin On Recovery Of Coronary Endothelial Function
  99. EPISTENTEvaluation Of Platelet IIb/IIia Inhibitor For Stenting Trial
  100. EPILOGEvaluation Of Ptca To Improve Long-Term Outcome By C7E3 Gp IIb/IIia Receptor (Abciximab) Blockade
  101. ERASEREvaluation Of Reopro And Stenting To Eliminate Restenosis
  102. ESCAMIEvaluation Of The Safety And Cardioprotective Effects Of Eniporide In Acute Myocardial Infarction
  103. ETHECCEvaluation Of Thymitaq In Hepatocellular Carcinoma
  104. EVIDENCEEvidence For Interferon Dose-Effect: European-North American Comparative Efficacy Study (Rebif V. Avonex In Relapsing-Remitting Multiple Sclerosis (Rrms))
  105. Biological evolutionEvolution
  106. EvolvedEvolution
  107. Theory of evolutionEvolution
  108. EvolutionaryEvolution
  109. Darwinian evolutionEvolution
  110. EvolveEvolution
  111. Evolutionary theory of sexEvolution of sex
  112. Ewan Cameron (Vitamin C)Ewan Cameron (physician)
  113. MOXCONExcess Mortality In Chf Patients Treated With Sr Moxonidine Leads To Study Termination: Results Of The Sr Moxonidine For Congestive Heart Failure Trial
  114. ERBACExcimer Laser, Rotational Atherectomy, Balloon Angioplasty Complications Study
  115. ELVD-CHFExercise In Left Ventricular Dysfunction And Chronic Heart Failure Trial
  116. ETICAExercise Training Intervention After Coronary Angioplasty: The Etica Trial
  117. Expectation maximizationExpectation-maximization algorithm
  118. PEPAFExperimental Program For Physical Activity Promotion
  119. Hyper-Cerebral ElectrosisExploding head
  120. EXCLAIMExtended Clinical Prophylaxis In Acutely Ill Medical Patients (Lovenox (Enoxaparin) Postmarketing (Phase Iv) Trial)
  121. ELATEExtended Low-Intensity Anticoagulation For Thrombo-Embolism Investigators
  122. EXCITeExtremity Constraint-Induced Therapy
  123. EASEEzetimibe Add-On To Statin Therapy For Effectiveness Trial
  124. FINESSEFacilitated Intervention With Enhanced Reperfusion Speed To Stop Events
  125. Choking gameFainting game
  126. Familial benign hypocalciuric hypercalcemiaFamilial Hypocalciuric hypercalcemia
  127. Vitamin E familial isolated, deficiency ofFamilial isolated vitamin e deficiency
  128. FRISCFast Revascularization During Instability In Coronary Artery Disease
  129. Fast FoodFast food
  130. FAATFatty Acid Antiarrhythmia Trial
  131. wikidoc:Faux pasFaux pas
  132. MusophobiaFear of mice
  133. 510(k)Federal Food, Drug, and Cosmetic Act
  134. Food, Drug, and Cosmetics Act AmendmentsFederal Food, Drug, and Cosmetic Act
  135. FD&CFederal Food, Drug, and Cosmetic Act
  136. FOODFeed Or Ordinary Diet
  137. Feline infectious peritonitis virusFeline infectious peritonitis
  138. Female circumcisionFemale genital cutting
  139. FASTFemoral Artery Stenting Trial
  140. Cathedia StudyFemoral Vs. Jugular Venous Catheterization And Risk Of Nosocomial Events In Adults Requiring Acute Renal Replacement Therapy
  141. Feral childrenFeral child
  142. Fibrillary astrocytomasFibrillary astrocytoma
  143. FASTERFibrinolytic And Aggrastat St Elevation Resolution First Abarelix Depot Study For Treating Endometriosis RapidlyFirst And Second Trimester Evaluation Of Risk
  144. FAST-MAGField Administration Of Stroke Therapy - Magnesium
  145. FIREFilterwire Ex Randomized Evaluation
  146. DeflagrationFire
  147. ISIS-1First International Study Of Infarct Survival
  148. FUTURE IFirst Use To Underscore Restenosis Reduction With Everolimus
  149. ARTS I - Five year follow-upFive Year Clinical Follow-Up Of The Arterial Revascularisation Therapy Study
  150. Upper flammable limitFlammability limit
  151. FlavorsFlavor
  152. Floating-pointFloating point
  153. Improving agentFlour treatment agent
  154. Fluid intelligenceFluid and crystallized intelligence
  155. FLORIDAFluvastatin On Risk Diminishing After Acute Myocardial Infarction
  156. FACITFolate After Coronary Intervention Trial
  157. FUSION IFollow-Up Serial Infusions Of Nesiritide Trial
  158. WikiDoc state of the art review on FondaparinuxFondaparinux detailed information
  159. FAOFood and Agriculture Organization
  160. Food colouringFood coloring
  161. Food Testing StripsFood testing strips
  162. ARCHeRFor Revascularization Of Carotids In High-Risk Patients
  163. Syst-EurFor The Syst-Eur Investigators. The Prevention Of Dementia With Antihypertensive Treatment. New Evidence From The Systolic Hypertension In Europe (Syst-Eur) Study
  164. DpfForm:DrugProjectForm
  165. Solar nebulaFormation and evolution of the Solar System#Formation of planets
  166. FOSITFosamax International Trial
  167. FESTFosinopril Efficacy/Safety Trial
  168. FAMISFosinopril In Acute Myocardial Infarction Study
  169. ISIS-4Fourth International Study Of Infarct Survival
  170. FractalsFractal
  171. FUSIONFractional Flow Reserve And Ultrasound Indices For Objective Narrowing Assessment
  172. FRISC IIFragmin And Fast Revascularization During Instability In Coronary Artery Disease
  173. Peyton RousFrancis Peyton Rous
  174. F.W. AstonFrancis William Aston
  175. Nissl methodFranz Nissl
  176. Nissl stainFranz Nissl
  177. FRAXISFraxiparin Versus Unfractionated Heparin In The Treatment Of Unstable Angina
  178. FRAXIS / FRAX.I.S.Fraxiparine In Ischemic Syndromes
  179. Frederick Augustus AbelFrederick Abel
  180. Frederick Grant BantingFrederick Banting
  181. FROSTYFreezor Trial Of Supraventricular Tachycardia
  182. FROSTFrench Optimal Stenting Trial
  183. August KekuleFriedrich August Kekulé von Stradonitz
  184. August KekuléFriedrich August Kekulé von Stradonitz
  185. Friedrich August KekuleFriedrich August Kekulé von Stradonitz
  186. KekuléFriedrich August Kekulé von Stradonitz
  187. FrowningFrown
  188. Fugu fishFugu
  189. Functional foodsFunctional food
  190. Félix d'HérelleFélix d'Herelle
  191. GalvanisationGalvanization
  192. Gamma butyrolactoneGamma-Butyrolactone
  193. GAMMA IIGamma II Localized Radiation Therapy To Inhibit Restenosis
  194. GAMMA VGamma V Localized Radiation Therapy To Inhibit Restenosis
  195. Gastric outlet obstruction surgeryGastric outlet obstruction Surgery
  196. Extreme lateral gazeGaze
  197. WikiDoc state of the art review on GemfibrozilGemfibrozil detailed information
  198. Cross-genderGender
  199. Binary genderGender binary
  200. Gender rolesGender role
  201. Gender theoryGender studies
  202. IntergenderGenderqueer
  203. G (factor)General intelligence factor
  204. General RelativityGeneral relativity
  205. GRASGenerally recognized as safe
  206. GenSaltGenetic Epidemiology Network Of Salt Sensitivity
  207. Genetic algorithmsGenetic algorithm
  208. DiscriminationGenetic discrimination
  209. Genital ulcer diseasesGenital Ulcer Disease
  210. VVCGenital candidiasis
  211. Genital modificationGenital modification and mutilation
  212. GART studyGenotypic Antiretroviral Resistance Testing
  213. George OlahGeorge Andrew Olah
  214. George D. SnellGeorge Davis Snell
  215. George PaladeGeorge Emil Palade
  216. George E. PaladeGeorge Emil Palade
  217. George GamovGeorge Gamow
  218. George H TichenorGeorge H. Tichenor
  219. George SternbergGeorge Miller Sternberg
  220. George Richards MinotGeorge Minot
  221. George BeadleGeorge Wells Beadle
  222. George Hoyt WhippleGeorge Whipple
  223. George H. WhippleGeorge Whipple
  224. Georges J.F. KohlerGeorges J. F. Köhler
  225. User:Gerald Chi.Gerald Chi, M.D.
  226. Gerald M. EdelmanGerald Edelman
  227. Gerhardus Johannes MulderGerardus Johannes Mulder
  228. GABI-2German Angioplasty Bypass Investigation - 2
  229. GABIGerman Angioplasty Vs. Bypass Surgery Investigation
  230. Giant cell tumor of bone chest x rayGiant cell tumor of bone x ray
  231. SmithKline BeechamGlaxoSmithKline
  232. GlenmarkGlenmark Pharmaceuticals Limited
  233. GOSPELGlobal Secondary Prevention Strategies To Limit Event Recurrence After Myocardial Infarction
  234. GUSTO-3Global Utilization Of Streptokinase And Tpa For Occluded Arteries-III
  235. GUSTO IIBGlobal Utilization Of Streptokinase And Tpa For Occluded Arteries IIb
  236. GUSTO-SPEEDGlobal Utilization Of Streptokinase And Tpa For Occluded Arteries–Strategies For Patency Enhancement In The Emergency Department
  237. GIPS IIGlucose - Insulin - Potassium Study In Patients With St Elevation Myocardial Infarction Without Signs Of Heart Failure
  238. GAMIGlucose Abnormalities In Patients With Myocardial Infarction: Prevalence, Diagnosis, And Prognostic Implications
  239. GEMINIGlycemic Effects In Diabetes Mellitus: Carvedilol - Metoprolol Comparison In Hypertensives Trial
  240. Godfrey Newbold HounsfieldGodfrey Hounsfield
  241. Godfrey N. HounsfieldGodfrey Hounsfield
  242. Gonococcal PharyngitisGonococcal pharyngitis
  243. The Pharmacological Basis of TherapeuticsGoodman & Gilman's The Pharmacological Basis of Therapeutics
  244. GRAPEGrampian Region Early Anistreplase Trial
  245. G-PADGranulocyte-Macrophage Colony Stimulating Factor In Patients With Intermittent Claudication
  246. Green CrossGreen Cross (Japan)
  247. Johann MendelGregor Mendel
  248. MendelGregor Mendel
  249. GISENGruppo Italiano Di Studi Epidemiologici In Nefrologia
  250. GISSI-1Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell'Infarto Miocardico Acuto-1

View ( | ) (20 | 50 | 100 | 250 | 500)